Glycomine
Emily Tess has worked in a variety of roles since 2014. In that year, they worked as an Undergraduate Research Assistant at Cornell University. In 2016, they held an R&D Intern position at Regeneron Pharmaceuticals, Inc. From 2017 to 2021, Emily worked at ClearView Healthcare Partners, where they held the roles of Engagement Manager, Senior Consultant, Consultant, and Analyst. In 2021, they became an Associate Director of Business Development & Strategy at Prothelia. Currently, Emily is the Chief of Staff, Director of Corporate Development & Strategy at Glycomine Inc.
Emily Tess attended Cornell University from 2011 to 2015, where they earned a Bachelor of Science in Biological Engineering. Emily then attended the University of Pennsylvania from 2015 to 2017, where they earned a Master of Science in Engineering in Bioengineering.
This person is not in any offices
Glycomine
1 followers
Glycomine is developing orphan drugs for serious rare disorders of metabolism and protein misfolding for which no other therapeutic options exist.